You are here: Industry Insights > PMDI

News List

Trial to evaluate inhaled COVID-19 therapy finishes enrolment europeanpharmaceuticalreview
January 19, 2021
The pilot study will determine whether an inhaled formulation of ensifentrine can expedite the recovery of patients hospitalised with COVID-19.
Verona completes enrolment in pilot study of potential COVID-19 inhaler pharmatimes
January 18, 2021
UK-headquartered Verona Pharma has completed enrolment in its pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19.
Verona progresses PhII trial of COPD inhaler pharmatimes
August 19, 2020
Verona Pharma is progressing a Phase II trial of new inhaler formulation of ensifentrine following a coronavirus pandemic-induced pause.
Environmentally friendly pressurised Metered Dose Inhaler to be developed europeanpharmaceuticalreview
December 09, 2019
A pharmaceutical company has announced its intention to create a pressurised Metered Dose Inhaler that will reduce the carbon footprint of the drug delivery system.